“…The efficacy of CAIP activation has been reported in animals and patients with inflammatory disorders. For example, the activation of the CAIP by α7nAChRs agonists can inhibit the excessive production of proinflammatory cytokines and improve clinical outcomes in animal models of sepsis and ALI/ARDS [ 109 , 115 , 121 , 123 , 142 ]. Electronic-based interventions, such as vagus nerve stimulation and electro-acupuncture points, can also decrease the levels of both proinflammatory cytokines, such as IL-4, IL-5, IL-6, IL-13, and inflammatory cell infiltration as seen in animal models of inflammatory diseases/disorders, including endotoxemia-induced ALI/sepsis [ [143] , [144] , [145] ].…”